Montgomery Kidney Specialists, LLP v. Physicians Choice Dialysis of Alabama, LLC

CourtDistrict Court, M.D. Alabama
DecidedFebruary 5, 2020
Docket2:17-cv-00668
StatusUnknown

This text of Montgomery Kidney Specialists, LLP v. Physicians Choice Dialysis of Alabama, LLC (Montgomery Kidney Specialists, LLP v. Physicians Choice Dialysis of Alabama, LLC) is published on Counsel Stack Legal Research, covering District Court, M.D. Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Montgomery Kidney Specialists, LLP v. Physicians Choice Dialysis of Alabama, LLC, (M.D. Ala. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF ALABAMA NORTHERN DIVISION

MONTGOMERY KIDNEY ) SPECIALISTS, LLP, et al., ) ) Plaintiffs, ) ) v. ) Civ. Act. No.: 2:17-cv-668-ECM ) (WO) PHYSICIANS CHOICE DIALYSIS ) OF ALABAMA, LLC, a wholly- ) owned subsidiary of DaVita, Inc., ) ) Defendant. )

MEMORANDUM OPINION and ORDER I. INTRODUCTION This case arises out of a complaint filed by Plaintiffs Montgomery Kidney Specialists, LLP, Charles Thomas, M.D., Rafael Lopez, M.D., and Jogy Varghese, M.D. seeking a declaratory judgment in the Montgomery County Circuit Court. On October 3, 2017, Defendant Physicians Choice Dialysis of Alabama, LLC, a wholly-owned subsidiary of DaVita, Inc., filed a notice of removal in this Court pursuant to 28 U.S.C. §§ 1332, 1441, and 1446. In response, the Plaintiffs filed a motion to remand the action to state court, alleging that the amount-in-controversy requirement was not met. Accordingly, the magistrate judge granted the Defendant’s motion for leave to conduct jurisdictional discovery regarding the amount in controversy. At the conclusion of jurisdictional discovery, the parties submitted supplemental briefing on the amount in controversy. On November 13, 2018, after the Eleventh Circuit’s decision in Fastcase, Inc. v. Lawriter, LLC, 907 F.3d 1335 (11th Cir. 2018), the parties again filed supplemental briefing.

Now pending before the Court are six motions: (1) the Defendant’s motion to transfer venue (doc. 3); (2) the Plaintiffs’ motion to remand (doc. 23); (3) a sealed motion (doc. 27); (4) Bio-Medical Applications of Alabama’s motion to intervene (doc. 44); (5) Fresenius Vascular Care Montgomery, LLP d/b/a Capitol City Vascular Center’s motion to intervene (doc. 46); and (6) the Defendant’s motion to strike. (Doc. 52). For the reasons that follow, the Plaintiffs’ motion to remand (doc. 23) is due to be

denied, the Defendant’s motion to transfer venue (doc. 3) is due to be granted, the sealed motion (doc. 27) is due to be denied as moot, and the Defendant’s motion to strike (doc. 52) is due to be denied as moot. Further, for the reasons discussed in Part III-D-ii, infra, the Court declines to rule on Bio-Medical Applications of Alabama’s motion to intervene (doc. 44) and Fresenius Vascular Care Montgomery, LLLP d/b/a Capitol City Vascular

Center’s motion to intervene. (Doc. 46). II. BACKGROUND The Plaintiffs, a nephrology practice1 and three physicians, contracted with the Defendant, a dialysis management company, to serve as medical directors for a dialysis clinic in Montgomery. (Doc. 2-1 at 9). The Plaintiffs brought a declaratory action in the

Circuit Court of Montgomery County, seeking a ruling that the Plaintiffs are not bound by

1 The Plaintiff nephrology practice is Montgomery Kidney Specialists, LLP. However, the Medical Director Agreement at issue was signed by a representative of Montgomery Kidney Specialists, LLC. See (Doc. 2-1 at 6); (Doc. 2-2 at 2, 49, 61); (Doc. 2-3 at 3, 5); see also discussion infra note 2. In its Answer to the Complaint, the Defendant “admits that the parties’ relationship is governed by the Medical Director Agreement that was executed in 2013.” (Doc. 4 at 4). the contract’s non-competition agreement (“NCA”). (Doc. 2-1 at 13). As mentioned above, the Defendant removed the action to this Court. (Doc. 2 at 25–26).

The parties agree that complete diversity exists among them. However, they dispute whether the value of the Plaintiffs’ declaratory judgment claim satisfies the amount in controversy requirement. (Doc. 2 at 2); (Doc. 23). Although the Plaintiffs seek a declaratory judgement that the NCA is invalid, the Plaintiffs stipulated that they do not seek and will not accept damages in excess of $74,000 exclusive of interest and costs. (Doc. 2-1 at 7). The Plaintiffs further stated: “[t]he value of the amount in controversy to Plaintiffs

will not exceed $74,000 exclusive of interest and costs.” (Id.). A. The Medical Director Agreement. Plaintiffs Charles Thomas, Rafael Lopez, and Jogy Varghese are “each members in Montgomery Kidney.”2 (Doc. 2-1 at 8). In 2006, Montgomery Kidney Specialists, LLC, by and through its physicians, began serving as medical director for the East Montgomery

Dialysis Center. (Doc. 2-1 at 9). This dialysis center is owned and operated by Defendant Physician’s Choice Dialysis of Alabama (“PCDA”). (Id. at 8–9). The medical director relationship between Montgomery Kidney Specialists, LLC and Defendant PCDA is governed by the Medical Director Agreement (“MDA”). (Id. at 9) (Doc. 2-2). The three Plaintiff physicians were joined to the MDA as representatives of Montgomery Kidney

2 The use of the word “members” indicates that the Plaintiffs are referring to Montgomery Kidney Specialists, LLC, as opposed to Montgomery Kidney Specialists, LLP, which is one of the Plaintiffs in this case. See ALA. CODE §§ 10A-5A-1.08; 10A-8A-10.01. However, the Plaintiffs defined “Montgomery Kidney” as Montgomery Kidney Specialists, LLP. (Doc. 2-1 at 6). Because the parties do not dispute that their relationship is governed by the 2013 Medical Director Agreement, the Court will resolve the pending motions without untangling this issue. Specialists, LLC. (Doc. 2-3 at 3). Additionally, Harinaga Garapati, M.D. was joined to the MDA as a representative of Montgomery Kidney Specialists, LLC. (Doc. 2-3 at 5). The

MDA contains two provisions that are relevant to the Court’s resolution of the pending motions. First, the MDA contains a forum-selection clause that serves as the basis for the Defendant’s motion to transfer venue: Legal Action. Any and all actions at law or equity taken to enforce, interpret, or otherwise address the provisions of this Agreement shall be filed: if in state court, with the Circuit Court for the Tenth Judicial Circuit of Alabama (Jefferson County), Birmingham Division; and if in federal court, then in the Federal District Court of the Northern District of Alabama, Middle Division, sitting in the City of Birmingham, Jefferson County, Alabama.

(Doc. 2-2 at 22). As pointed out by the Defendant, the clause requires any legal action in federal court to be filed in the “Northern District of Alabama, Middle Division, sitting in the City of Birmingham, Jefferson County, Alabama[,]” but the City of Birmingham and Jefferson County are actually in the Southern Division of the Northern District of Alabama. (Doc. 22 at 18). Accordingly, the Defendant’s motion to transfer seeks to transfer the case to the “Southern Division” (doc. 3 at 1), notwithstanding the forum-selection clause specifying the “Middle Division.” (Doc. 2-2 at 22). Second, the MDA contains the NCA that the Plaintiffs wish to have invalidated. (Id.). The NCA provides that Montgomery Kidney Specialists, LLC, for two years after the agreement is signed, will not directly or indirectly: (a) Take any action that results or may reasonably be expected to result in owning any interest in, leasing, operating, managing, extending credit to, or otherwise participating in the business (including, without limitation, as a medical director, contractor, consultant or employee) of a Competitor in the Restricted Area; or

(b) Own any interest in, lease, operate, manage, extend credit to, or otherwise participate in the business (including, without limitation, as a medical director, contractor, consultant or employee) of a Competitor in the Restricted Area.

(Doc. 2-2 at 18). The “Restricted Area” is defined as:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

University of South Alabama v. American Tobacco Co.
168 F.3d 405 (Eleventh Circuit, 1999)
Miriam W. Williams v. Best Buy Co., Inc.
269 F.3d 1316 (Eleventh Circuit, 2001)
William S. Manuel v. Convergys Corporation
430 F.3d 1132 (Eleventh Circuit, 2005)
Jimmy T. Bauknight v. Monroe County, Florida
446 F.3d 1327 (Eleventh Circuit, 2006)
Piper Aircraft Co. v. Reyno
454 U.S. 235 (Supreme Court, 1982)
City of Mesquite v. Aladdin's Castle, Inc.
455 U.S. 283 (Supreme Court, 1982)
Stewart Organization, Inc. v. Ricoh Corp.
487 U.S. 22 (Supreme Court, 1988)
Andrew Pretka v. Kolter City Plaza II, Inc.
608 F.3d 744 (Eleventh Circuit, 2010)
Weiner v. Tootsie Roll Industires, Inc.
412 F. App'x 224 (Eleventh Circuit, 2011)
Larry Bonner v. City of Prichard, Alabama
661 F.2d 1206 (Eleventh Circuit, 1981)
Geoffrey Scimone v. Carnival Corporation
720 F.3d 876 (Eleventh Circuit, 2013)
Gould v. National Life Insurance
990 F. Supp. 1354 (M.D. Alabama, 1998)
Callen v. Callen
827 F. Supp. 2d 214 (S.D. New York, 2011)
Babasola Kolawole v. Stacy Sellers
863 F.3d 1361 (Eleventh Circuit, 2017)
Fastcase, Inc. v. Lawriter, LLC
907 F.3d 1335 (Eleventh Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Montgomery Kidney Specialists, LLP v. Physicians Choice Dialysis of Alabama, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/montgomery-kidney-specialists-llp-v-physicians-choice-dialysis-of-almd-2020.